banner
Inquiry

Cat. No.: X23-04-XQ423

Astilbin

Synonym: 29838-67-3; Astilbin; Isoastilbin; Taxifolin 3-O-rhamnoside; Neoisoastilbin; Taxifolin 3-rhamnoside; Dihydroquercitrin; Dihydroquercetin 3-rhamnoside

  • MDL: MFCD20274680
  • CAS Number: 29838-67-3
  • Compound CID: 119258
img
Product Size
20 mg; 50 mg; 100 mg; 200 mg; 500 mg; 1 g
Price
Datasheet
MSDS
Properties
Description
Astilbin, as a compound of flavonoids, exerts anti-inflammation, antioxidation, and immune-suppression activities.
Molecular Weight
450.39
Molecular Formula
C21H22O11
Source
Astilbe chinensis
Form
Colorless crystal
Purity
>98%, determined by HPLC.
Solubility
It is easily soluble in boiling water and almost insoluble in ether.
Identity
Confirmed by NMR and MS.
Melting Point
180°C
Applications
Astilbin can be used for anti-inflammation, antioxidation, and immune-suppression activity experiments, etc.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.
0